Roche Access for Patients (RAP) Program

Pangalan ng Kumpanya: 

Roche (Philippines) Inc.

Taon na nagsimula ang programa:
Oct 2011
Para sa anong kondisyon ito?
Cancer (Breast, Colorectal, Lung, Non-Hodgkin’s Lymphoma, and Ovarian)
Para kanino ang programa?
For patients prescribed with trastuzumab, rituximab, erlotinib, and bevacizumab.
Deskripsyon ng programa:
Roche Access for Patients (RAP) program aims to improve access to cancer patients prescribed with the Roche Oncology Brands (trastuzumab, rituximab, erlotinib, and bevacizumab). Program mechanics:
1. Tiered Pricing/Differentiated discount based on economic class     
2. Enrolment through the attending physician
3. Credit investigation component (CIBI)
4. Call Center Helpdesk (provides instructions and directs patients thru the process)
5. Availment of discount through an accredited sub-distributor/hospital

Saan maaaring pumunta?

Please consult and seek referral from a Medical Oncologist.

Saan tatawag para sa mga katanungan tungkol sa programa?

Please contact (02) 718-7640.